GlassScriptPhysician profile
Christina Rose Bellinger
NPI 1205023025
$31,887.00
in general payments reported to CMS, 2019-2025
12 companies · $14K in 2025
The $14K reported for 2025 was more than what 94% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2020: $142 · 2021: $247 · 2022: $1,520 · 2023: $4,315 · 2024: $12K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $15K · Honoraria: $7,050 · Education: $4,807 · Food and Beverage: $1,640 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500 · Consulting Fee: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $15,480.75 |
| Honoraria | $7,050.00 |
| Education | $4,807.25 |
| Food and Beverage | $1,640.02 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
| Consulting Fee | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mirati Therapeutics, INC. | $12,549.20 | 2025 | |
| Intuitive Surgical, INC. | $10,312.49 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Elucent Medical | $6,300.00 | 2024 | |
| Pulmonx Corporation | $1,116.76 | 2020-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Cook Incorporated | $750.00 | 2024 | |
| Galvanize Therapeutics, INC | $426.88 | 2023-2024 | Aliya System |
| Optellum LTD | $150.00 | 2025 | |
| Olympus America INC. | $117.14 | 2025 | |
| Pinnacle Biologics, INC | $61.41 | 2025 | Photofrin |
| Imbio INC. | $56.50 | 2023 | Imbio Lung Density Analysis |
| Olympus Corporation of The Americas | $25.76 | 2019 | |
| Gilead Sciences, INC. | $20.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Bellinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.